InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0000899243-23-003891 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-03 2023-02-01 TMDX Carey John F VP of Ops S - Sale+OE $63.14 -1,410 14.3K -9% -$89.0K
DM 2023-02-03 2023-02-01 TMDX Carey John F VP of Ops M - OptEx $16.88 +1,410 15.5K +10% +$23.8K
DM 2023-02-03 2023-02-01 TMDX Carey John F VP of Ops M - OptEx $0.00 -1,410 4,887 -22% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-01 S D 214 $65.81 14,120 D — — (F6) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $65.45 to $65.96, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2 Common Common Stock 2023-02-01 S D 96 $64.04 14,473 D — — (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.43 to $64.41, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2023-02-01 M A 1,363 $16.14 15,483 D — —
4 Common Common Stock 2023-02-01 M A 47 $38.46 15,530 D — —
5 Common Common Stock 2023-02-01 S D 582 $62.00 14,948 D — — (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.23 to $62.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
6 Common Common Stock 2023-02-01 S D 379 $62.52 14,569 D — — (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.23 to $63.02, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
7 Common Common Stock 2023-02-01 S D 139 $64.88 14,334 D — — (F5) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.45 to $65.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
8 Derivative Stock Option (Right to Buy) 2023-02-01 M D 47 $0.00 13,543 D $38.46 · — to 2031-02-24 47 Common Stock (F8) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
9 Derivative Stock Option (Right to Buy) 2023-02-01 M D 1,363 $0.00 4,887 D $16.14 · — to 2030-02-27 1,363 Common Stock (F7) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.